Ilkka Kantola
Professor; Head of Medical Division, Turku university Hospital
Hypertensio;Fabry disease; diabetes mellitus; sleep apnea
- Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients (2017)
- New England Journal of Medicine
Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC; SPIRE Cardiovascular Outcome Investigators.
- Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease (2017)
- New England Journal of Medicine
HPS3/TIMI55–REVEAL Collaborative Group, Bowman L, Hopewell JC, Chen F, Wallendszus K, Stevens W, Collins R, Wiviott SD, Cannon CP, Braunwald E, Sammons E, Landray MJ.
- Home versus office blood pressure: longitudinal relations with left ventricular hypertrophy: the Finn-Home study (2017) Siven SSE, Niiranen TJ, Langen VLJ, Puukka PJ, Kantola IM, Jula AM
- Improved control of blood pressure and albuminuria among patients with type-2 diabetes in Finnish open care (2017) Varis J, Metsärinne K, Koivisto V, Niskanen L, Rissanen A, Virkamäki A, Appelroth T, Pöntynen N, Poussa T, Kantola I
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease (2017)
- New England Journal of Medicine
Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Stork S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Bruns NC, Misselwitz F, Chen E, Leong D, Yusuf S; for the COMPASS Investigators
- Safety, Tolerability, and Antihypertensive Effect of SER100, an Opiate Receptor-Like 1 (ORL-1) Partial Agonist, in Patients With Isolated Systolic Hypertension (2017)
- Clinical Pharmacology in Drug Development
Kantola I, Scheinin M, Gulbrandsen T, Meland N, Smerud KT
- Screening, diagnosis, and management of patients with Fabry disease: conlusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) controversies conference (2017) Schiffmann R, Hughess DA, Linthorst GE, Ortiz A, Svarstad E, Warnock DG, West ML, Wanner C; for Conference Participants
- Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis (2017) Tucker KL, Sheppard JP, Stevens R, Bosworth HB, Bove A, Bray EP, Earley K, George J, Godwin M, Greee BB, Hebert P, Hobbs FDR, Kantola I, Kerry SM, Leiva A, Magid DJ, Mant J, Margolis KL, McKinstry B, McLaughlin MA, Omboni S, Ogedegbe O, Parati G, Qamar N, Tabaei BP, Varis J, Verberk WJ, Wakefield BJ, McManus RJ, McManus RJ
- Tyytyväinen erikoistuja on koko klinikan etu (2017) Valta M, Kantola I
- Valkotakkihypertensio (2017) Juhanoja Eeva, Johansson Jouni, Kantola Ilkka, Jula Antti, Niiranen Teemu
